Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 16.57.
Forward PE Ratio (16.57) = Close Price ($82.54) / Consensus Forward EPS ($4.98)
FORWARD PE RATIO
16.57
SECTOR MEDIAN · HEALTHCARE
20.29
median of 78 covered companies
CURRENT VS SECTOR MEDIAN
-18.31%
vs the sector median at left
Globus Medical, Inc.
Market Cap
$11.13B
Forward PE Ratio
16.57
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Globus Medical, Inc. (GMED) | $11.13B | 16.57 |
| Bio-Techne Corporation (TECH)vs › | $11.35B | 37.68 |
| Align Technology, Inc. (ALGN)vs › | $11.38B | 14.09 |
| DaVita Inc. (DVA)vs › | $11.48B | 12.13 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.50B | 40.31 |
| Universal Health Services, Inc. (UHS)vs › | $10.45B | 7.65 |
| Encompass Health Corporation (EHC)vs › | $11.86B | 19.56 |
| Molina Healthcare, Inc. (MOH)vs › | $10.37B | N/A |
| Henry Schein, Inc. (HSIC)vs › | $10.28B | 16.79 |
| The Ensign Group, Inc. (ENSG)vs › | $10.11B | 22.26 |
Trailing P/E
21.2
reported TTM EPS
Forward P/E
16.6
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $4.98 implies +28.0% EPS growth vs the reported trailing $3.89.
At today's $82.54 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $4.98 | $4.79 – $5.05 | 8 | 16.6x |
| 2027-12-31 | $5.35 | $4.79 – $5.67 | 8 | 15.4x |
| 2028-12-31 | $5.86 | $5.23 – $6.74 | 4 | 14.1x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
